Sarah Cannon appoints deputy physician-in-chief of blood cancers
Click Here to Manage Email Alerts
Navneet Majhail, MD, MS, FASTCT, has been appointed deputy physician-in-chief of blood cancers for Sarah Cannon Transplant and Cellular Therapy Network.
Majhail also will serve as program medical director for Sarah Cannon transplant and cellular therapy program at Centennial Medical Center in Nashville.
His appointment will take effect in September.
Majhail currently serves as director of Cleveland Clinic’s blood and marrow transplant program, as well as vice chair for the department of hematology and medical oncology and professor of medicine with Cleveland Clinic Lerner College of Medicine.
He is recognized for his contributions to health outcomes research, as well as his work related to the prevention and management of complications of hematopoietic cell transplantation and health policy issues, such as health care disparities, quality of care, survivorship and economic issues related to transplantation and cellular therapy.
He is past president of American Society for Transplantation and Cellular Therapy.
“We are delighted that Dr. Majhail is joining Sarah Cannon and will work alongside our teams to foster an increased collaboration across our six U.S. and three U.K. blood cancer programs,” Fred LeMaistre, MD, senior vice president for Sarah Cannon market operations and physician-in-chief of blood cancers, said in a press release. “His incredible depth and breadth of experience — not only at the bedside, but also as a strategic thinker, researcher and coupled with his experience in regulatory and policy issues — will bring great value to our network and the patients we serve.”
Click Here to Manage Email Alerts